The Synthetic Blood Substitutes And Blood Products Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of synthetic blood substitutes and blood products has experienced quick expansion recently. The market value increased from $6.55 billion in 2024 and is expected to reach $7.62 billion in 2025. The predicted compound annual growth rate (CAGR) is 16.3%.
The Synthetic Blood Substitutes And Blood Products Global Market Report 2025 projects that the market size will reach $13.76 billion in 2029, and is expected to grow at a compound annual growth rate (CAGR) of 15.9%.
Download Your Free Sample of the 2025 Synthetic Blood Substitutes And Blood Products Market Report and Uncover Key Trends Now!The key drivers in the synthetic blood substitutes and blood products market are:
• Expanding applications of synthetic blood substitutes and blood products in military and disaster response
• Rising awareness of alternative blood substitutes
• Growing prevalence of blood-related disorders
• Increasing incidence of trauma and emergency surgeries
The synthetic blood substitutes and blood products market covered in this report is segmented –
1) By Type: Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander
2) By Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications
3) By End-User: Hospitals And Clinics, Blood Banks, Other End users
Subsegments:
1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products, Non-Emulsion-Based Products
2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products
3) By Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors
4) By Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors
5) By Blood Expander: Colloid Solutions, Crystalloid Solutions
The key trends in the synthetic blood substitutes and blood products market are:
• The development of hemoglobin-based oxygen carriers is an emerging trend.
• Regulatory approvals and research are significantly shaping the future market.
• Advancements in biotechnology are increasingly influencing the field.
• The integration of artificial intelligence (AI) into medicine is a growing trend.
Major players in the synthetic blood substitutes and blood products market are:
• Takeda Pharmaceutical Company Limited
• Fresenius Kabi AG
• Baxter International Inc.
• Octapharma AG
• Green Cross Corporation
• Alliance Pharmaceutical Corporation
• Hemosol Inc.
• Sanguine Corporation
• Sangart Inc.
• Biopure Corporation
• Tenex Therapeutics
• Velico Medical
• Hemarina S.A.
• KaloCyte Inc.
• Aurum Biosciences Limited
• SpheriTech Limited
• Dendritech Inc.
• HbO2 Therapeutics LLC
• HemoBioTech Inc.
• Somatogen Inc.
North America was the largest region in the synthetic blood substitutes and blood products market in 2024